GlassScriptPhysician profile
Jonathan D Slusser
NPI 1750644704
$1,721.93
in general payments reported to CMS, 2019-2025
18 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $70.23 · 2021: $12.24 · 2022: $101 · 2023: $99.90 · 2024: $283 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633 · Gift: $59.40 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.31 |
| Gift | $59.40 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $318.43 | 2019-2020 | |
| Abbott Laboratories | $299.05 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $210.06 | 2022-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $152.44 | 2019 | |
| Medtronic, INC. | $145.96 | 2021-2025 | Minimed 780g |
| Lilly USA, LLC | $121.29 | 2019-2022 | |
| Medtronic Minimed, INC. | $93.08 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $86.87 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $79.40 | 2023 | Afrezza |
| Amgen INC. | $44.87 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $35.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.24 | 2019 | |
| Antares Pharma, INC. | $24.00 | 2019 | |
| Becton, Dickinson and Company | $21.55 | 2019 | |
| Jazz Pharmaceuticals INC. | $20.08 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.49 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $15.35 | 2024 | |
| Shire North American Group INC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Slusser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.